Kenneth C. Frazier
2014
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $3,642,161 |
---|---|
Non-Equity Incentive Plan | $3,341,250 |
Option Awards | $3,323,244 |
Salary | $1,500,000 |
Stock Awards | $13,025,313 |
Other | $197,402 |
Total | $25,029,370 |
Frazier received $13M in stock awards, accounting for 52% of the total pay in 2014.
Frazier also received $3.6M of change in pension value and nonqualified deferred compensation earnings, $3.3M in non-equity incentive plan, $3.3M in option awards, $1.5M in salary and $197.4K in other compensation.
Rankings
In 2014, Kenneth C. Frazier's compensation ranked 78th out of 13,032 executives tracked by ExecPay. In other words, Frazier earned more than 99.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 78 | 99th |
Manufacturing | 28 | 99th |
Chemicals And Allied Products | 13 | 99th |
Drugs | 12 | 99th |
Pharmaceutical Preparations | 12 | 99th |
Frazier's colleagues
We found five more compensation records of executives who worked with Kenneth C. Frazier at Merck & Co. in 2014.
2014
Robert Davis
Merck & Co.
Chief Financial Officer
2014
Adam Schechter
Merck & Co.
Executive Vice President and President, Global Human Health
2014
Roger Perlmutter
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
2014
Bruce Kuhlik
Merck & Co.
General Counsel
2014
Peter Kellogg
Merck & Co.